It has been reported that the anti-cancer activities of cordycepin can be mediated by several putative receptors, such as adenosine receptors (ARs) [20,67,68], death receptors (DRs) [69,70], and the epidermal growth factor receptor (EGFR) [23,24]. Here, EGFR is linked to cancer.